These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6300933)

  • 1. Opiate-receptor blockade reduces voluntary running but not self-stimulation in hamsters.
    Potter CD; Borer KT; Katz RJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):217-23. PubMed ID: 6300933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation.
    Schenk S; Nawiesniak E
    Pharmacol Biochem Behav; 1985 Feb; 22(2):175-7. PubMed ID: 2984700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of hippocampal progenitor proliferation by opioid receptor antagonists in running and non-running spontaneously hypertensive rats.
    Persson AI; Naylor AS; Jonsdottir IH; Nyberg F; Eriksson PS; Thorlin T
    Eur J Neurosci; 2004 Apr; 19(7):1847-55. PubMed ID: 15078558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth.
    Zagon IS; McLaughlin PJ
    Life Sci; 1984 Nov; 35(20):2057-64. PubMed ID: 6092812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone fails to suppress spontaneous locomotor activity in hamsters.
    Lowy MT; Sangiah S; Yim GK
    Pharmacol Biochem Behav; 1985 Mar; 22(3):399-401. PubMed ID: 3991756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locomotor activity and opiate effects in male and female hamsters.
    Schnur P; Barela P
    Pharmacol Biochem Behav; 1984 Sep; 21(3):369-74. PubMed ID: 6494208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of pulsatile growth hormone secretion by growth-inducing exercise: involvement of endogenous opiates and somatostatin.
    Borer KT; Nicoski DR; Owens V
    Endocrinology; 1986 Feb; 118(2):844-50. PubMed ID: 2867892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal serotonin mediates hypoactivity in dietarily obese hamsters: a possible manifestation of aging?
    Borer KT; Bonna R; Kielb M
    Pharmacol Biochem Behav; 1988 Dec; 31(4):885-92. PubMed ID: 3252281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate modification of intracranial self-stimulation in the rat.
    Weibel SL; Wolf HH
    Pharmacol Biochem Behav; 1979 Jan; 10(1):71-8. PubMed ID: 441097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters.
    Snodgrass-Belt P; Gilbert JL; Davis FC
    Brain Res; 2005 Mar; 1038(2):171-82. PubMed ID: 15757633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit.
    Trujillo KA; Belluzzi JD; Stein L
    Brain Res; 1989 Jul; 492(1-2):15-28. PubMed ID: 2752295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
    Todtenkopf MS; Marcus JF; Portoghese PS; Carlezon WA
    Psychopharmacology (Berl); 2004 Apr; 172(4):463-70. PubMed ID: 14727002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.
    Nakajima S; McKenzie GM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):919-23. PubMed ID: 3520603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic self-stimulation under the chronic morphine treatment in the rat.
    Zvartau EE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):707-19. PubMed ID: 558644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu opioid receptor modulation in the nucleus accumbens lowers voluntary wheel running in rats bred for high running motivation.
    Ruegsegger GN; Toedebusch RG; Will MJ; Booth FW
    Neuropharmacology; 2015 Oct; 97():171-81. PubMed ID: 26044640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status.
    Jones JE; Corp ES
    Physiol Behav; 2003 Jan; 78(1):67-72. PubMed ID: 12536012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific naloxone blockade of brain self-stimulation duration.
    Freedman NL; Pangborn D
    Pharmacol Biochem Behav; 1984 Mar; 20(3):361-6. PubMed ID: 6608735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Life Sci; 1985 Jul; 37(2):169-76. PubMed ID: 2989642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptors modulate estrogen-induced cholecystokinin and tachykinin but not enkephalin messenger RNA levels in the limbic system and hypothalamus.
    Eckersell CB; Micevych PE
    Neuroscience; 1997 Sep; 80(2):473-85. PubMed ID: 9284350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.